United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Armas Pharmaceuticals launches first injectable in US with Vidaza generic Armas Pharmaceuticals has entered the US injectable drug market with its launch of Azacitidine for Injection 100 MG,… bypharmanewsdailyNovember 19, 2018